Kwaku Ohene-Frempong, MD Named a 2021 Honorific Award Recipient by the American Society of Hematology
Published on
Kwaku Ohene-Frempong, MD was named a 2021 Honorific Award Recipient by the American Society of Hematology.
Sickle Cell Center News and Updates
1 - 10 of 18
CHOP Gene Therapy Experts Profiled in Philadelphia Magazine
Published on
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
CHOP Expert Featured on NBC News
Published on
Fears of catching Covid-19 in ERs forced many in the throes of pain crises to avoid seeking medical attention. Dr. Kim Smith-Whitley explains the importance of seeking care in a COVID-19 world.
Sickle Cell and Covid-19
Published on
Millions of Americans carry the sickle cell trait, many without knowing it. Could they be at risk for severe Covid-19? Stat News Reports.
CHOP Expert Commentary – Impact of COVID-19 on African American Community
Published on
Learn how Kim Smith-Whitley, MD, is fighting to improve the lives of her patients in the wake of COVID-19.
Breakthrough New Therapies Approved for the Treatment of Sickle Cell Disease
Published on
The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
CHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Published on
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
CHOP Volunteers Make Camp Special
Published on
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.
Sickle Cell Patient Featured on Seeking Solutions with Suzanne
Published on
Born with sickle cell disease, Naomi receives breakthrough treatments and screenings at CHOP to keep her symptoms in check and protect her from strokes.
Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease, Thalassemia
Published on
Researchers have found a key protein that could become a target for a new treatment for sickle cell disease. In lab tests, blocking the protein reduces sickling that distorts red blood cells.